Home › Endometrial Cancer › Hawaii › Honolulu
Endometrial Cancer clinical trials in Honolulu, HI
3 studies for Endometrial Cancer are looking for participants at sites in and around Honolulu (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
- Queen's Cancer Cenrer - POB I, Honolulu
- Queen's Medical Center, Honolulu
- and 7 more
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RecruitingPhase 3
- Kaiser Permanente Moanalua Medical Center, Honolulu
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
RecruitingPhase 3
- Research Site, Honolulu
Endometrial Cancer trials in other cities
- Houston, TX68 studies
- New York City, NY52 studies
- Boston, MA50 studies
- Arlington, VA39 studies
- Nashville, TN38 studies
- Los Angeles, CA34 studies
- St. Louis, MO29 studies
- Philadelphia, PA28 studies
- San Antonio, TX27 studies
- Queens, NY25 studies
- Columbus, OH25 studies
- Chicago, IL25 studies
Other studies in Honolulu
- Cancer (all types)13 studies
- Obesity13 studies
- Breast Cancer12 studies
- Overweight11 studies
- Non-Small Cell Lung Cancer10 studies
- Lung Cancer8 studies
- Acute Myeloid Leukemia7 studies
- Type 2 Diabetes7 studies
- Ovarian Cancer7 studies
- Pancreatic Cancer7 studies
- Neuroblastoma6 studies
- Prostate Cancer5 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.